Your browser doesn't support javascript.
loading
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
Cuello, M; Ettenberg, S A; Clark, A S; Keane, M M; Posner, R H; Nau, M M; Dennis, P A; Lipkowitz, S.
Affiliation
  • Cuello M; Genetics Department, Medicine Branch, National Cancer Institute, Bethesda, Maryland 20889, USA.
Cancer Res ; 61(12): 4892-900, 2001 Jun 15.
Article in En | MEDLINE | ID: mdl-11406568
Search on Google
Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Membrane Glycoproteins / Tumor Necrosis Factor-alpha / Protein Serine-Threonine Kinases / Apoptosis / Receptor, ErbB-2 / Antibodies, Monoclonal / Antineoplastic Agents Limits: Female / Humans Language: En Year: 2001 Type: Article
Search on Google
Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Membrane Glycoproteins / Tumor Necrosis Factor-alpha / Protein Serine-Threonine Kinases / Apoptosis / Receptor, ErbB-2 / Antibodies, Monoclonal / Antineoplastic Agents Limits: Female / Humans Language: En Year: 2001 Type: Article